Kalio Jodidas Serb (Potassium Iodide)

Potassium iodide supplies a large amount of stable iodine that saturates the thyroid’s sodium‑iodide symporter. This saturation temporarily blocks the organification of iodine, preventing the thyroid from taking up any radioactive iodine that may be present, thereby reducing radiation‑induced thyroid injury.

The appropriate dose of Kalio Jodidas Serb is determined by a qualified prescriber based on the specific indication, patient age, weight, and clinical circumstances. Healthcare professionals follow national or institutional guidelines to decide the exact amount and timing of administration.

Safety data for potassium iodide in pregnancy and lactation are limited. Use is generally reserved for situations where the benefit outweighs potential risk, such as radiation exposure. Pregnant or breastfeeding individuals should discuss the need for treatment with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Kalio Jodidas Serb contains the same active ingredient—potassium iodide—as other branded or generic stable‑iodine tablets. Differences may lie in manufacturing standards, regulatory approvals, and packaging. GNH India ensures EU‑compliant quality and GDP‑certified supply, which can be advantageous for international procurement.

Store the product at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight, and extreme humidity. Keep the container tightly closed and out of reach of children.

Kalio Jodidas Serb is taken orally, usually as a single dose or as directed by a healthcare professional. The tablet or liquid should be swallowed with water, following any specific timing recommendations related to potential radiation exposure.

Serious risks include severe allergic reactions such as anaphylaxis, angioedema, and thyrotoxicosis, which can lead to excessive thyroid hormone release. Prompt medical attention is required if symptoms like difficulty breathing, swelling of the face or throat, or rapid heart rate occur.

Individuals with known hypersensitivity to potassium iodide or any component of the formulation should avoid it. Patients with uncontrolled hyperthyroidism, certain thyroid disorders, or those taking medications that may cause dangerous interactions should only use it under strict medical supervision.